West Pharmaceutical Services Inc

Research West Pharmaceutical Services Inc (WST) on Bullrun: valuation model: 17.0% overvalued, market cap USD 25.06B, P/E 47.4, dividend yield 0.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks West Pharmaceutical Services Inc as 17.0% overvalued; latest market cap is USD 25.06B; P/E is 47.4; dividend yield is 0.2%.

About West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems;

Frequently asked questions

Is West Pharmaceutical Services Inc overvalued or undervalued?

Bullrun's valuation model currently marks West Pharmaceutical Services Inc as 17.0% overvalued.

What is West Pharmaceutical Services Inc's market cap?

West Pharmaceutical Services Inc's market capitalization is USD 25.06B.

What is West Pharmaceutical Services Inc's P/E ratio?

West Pharmaceutical Services Inc's price-to-earnings (P/E) ratio is 47.4.

Does West Pharmaceutical Services Inc pay a dividend?

West Pharmaceutical Services Inc has a dividend yield of 0.2%.

What does West Pharmaceutical Services Inc do?

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.